Vivos Therapeutics Inc (VVOS) — Strategic Asset Allocation Index
Vivos Therapeutics Inc (VVOS) has a Strategic Asset Allocation Index of 228.4% as of June 2023. Strategic assets (PP&E of $4.81 Million plus long-term investments of $-) total $4.81 Million, measured against net assets of $2.11 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see market cap of Vivos Therapeutics Inc.
SAAI
Strategic Assets
PP&E
Net Assets
Vivos Therapeutics Inc Strategic Asset Allocation Index (2018–2021)
This chart shows how Vivos Therapeutics Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of June 2023, the index stands at 228.4%, representing strategic assets of $4.81 Million against net assets of $2.11 Million USD. See Vivos Therapeutics Inc (VVOS) net asset quality to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Vivos Therapeutics Inc (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Vivos Therapeutics Inc from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore VVOS net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 11.1% | $2.83 Million | $2.83 Million | $- | $25.54 Million | ▲ +5.9 pp |
| 2020 | 5.2% | $871.60K | $871.60K | $- | $16.92 Million | ▼ -21.4 pp |
| 2018 | 26.6% | $1.28 Million | $1.28 Million | $- | $4.83 Million | — |